The lung cancer surgery market comprises key products such as endobronchial valves, bronchoscopes, ultrasound systems, cauterizing and electrosurgical devices, cutting instruments, and surgical staplers that are used for diagnostic as well as surgical procedures to treat lung cancer. Lung cancer surgeries, including wedge resection, lobectomy, and pneumonectomy, are mainly performed to remove part of or the entire lung containing cancer cells. Advancement in techniques such as video-assisted thoracic surgery (VATS) allows minimally invasive surgery with smaller incisions. The global lung cancer surgery market is estimated to be valued at US$ 6.04 billion in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The lung cancer surgery market is expected to be flourished by Advancement in lung cancer surgery techniques. One such driver is advancement in video-assisted thoracic surgery (VATS) which allows lung cancer surgery to be performed through small incisions using an endoscope rather than through large incisions. VATS requires only three small incisions rather than one large incision, leading to less pain, a shorter hospital stay and faster recovery as compared to traditional open surgery. Advancement in VATS technology enables surgeons to perform complex surgeries such as lobectomy which were previously difficult through small incisions. This has increased preference for minimally invasive techniques among surgeons and patients alike. The growing adoption of minimally invasive techniques such as VATS is expected to boost the overall lung cancer surgery market during the forecast period.

Segment Analysis
The Global Lung Cancer Surgery Market Share is segmented into non-small cell lung cancer and small cell lung cancer. Non-small cell lung cancer is the dominating sub-segment and accounts for around 85% of all lung cancer cases. This is because non-small cell lung cancer grows and spreads more slowly than small cell lung cancer. The three main types of non-small cell lung cancer are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma is the most common type.

PEST Analysis
Political: Governments across various countries are increasing funding for cancer research and treatment. Laws and regulations related to smoking and pollution control are being strengthened which will aid in reducing lung cancer incidence rates.
Economic: Rising healthcare expenditures, growing per capita incomes, and increasing focus on early diagnosis and treatment are fueling market growth. However, high costs associated with lung cancer surgery procedures can restrain the market to some extent.
Social: Growing public awareness about lung cancer symptoms and risk factors through various awareness campaigns is encouraging people to seek timely medical advice. Sedentary lifestyle and pollution levels are some of the key social factors contributing to the lung cancer burden.
Technological: Advancements in minimally invasive surgery technologies like robotic-assisted surgeries and video-assisted thoracic surgeries (VATS) allow conducting complex procedures with lesser pain and quicker recovery times for patients. Novel diagnostic tools also aid in detecting cancer at earlier stages.

Key Takeaways
The global lung cancer surgery market is expected to witness high growth over the forecast period. The increasing preference for minimally invasive techniques and rising lung cancer incidence worldwide will support the demand.

Regional analysis: North America accounts for the largest share in the lung cancer surgery market. This is attributed to factors such as new product approvals, presence of major manufacturers, rising research activities for advanced therapies, and growing awareness levels. The Asia Pacific region is expected to grow at the fastest pace driven by increasing healthcare investments, growing cancer prevalence, and expanding medical tourism in the region.

Key players operating in the lung cancer surgery market are Bunge Limited, Archer Daniels Midland Company, Cargill, Incorporated, Wilmar International Limited, Tyson Foods, Inc.,JBS S.A.,Darling Ingredients Inc.,IOI Corporation Berhad, Ventura Foods, LLC,BRF S.A., Ajinomoto Co., Inc., Premium Vegetable Oils Sdn Bhd, AAK AB, Conagra Brands, Inc., Richardson International Limited. Bunge Limited dominates with wide product portfolio and global presence. Archer Daniels Midland Company leads due to strong distribution networks across major markets.

For more details on the report, Read- https://www.pressreleasebulletin.com/lung-cancer-surgery-market-trends-size-and-share-analysis/

Check below trending articles Related to this topic: https://www.shayaricenter.com/understanding-cancer-biomarkers